These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6615938)

  • 21. The frequency response of horizontal pursuit movements of the human eye and the influence of alcohol.
    Drischel H
    Prog Brain Res; 1968; 22():161-74. PubMed ID: 5651164
    [No Abstract]   [Full Text] [Related]  

  • 22. Eye tracking in patients with unipolar and bipolar affective disorders in remission.
    Iacono WG; Peloquin LJ; Lumry AE; Valentine RH; Tuason VB
    J Abnorm Psychol; 1982 Feb; 91(1):35-44. PubMed ID: 7056941
    [No Abstract]   [Full Text] [Related]  

  • 23. Patterns of response to amitriptyline and haloperidol among borderline patients.
    Soloff PH; George A; Nathan RS; Schulz P; Cornelius J
    Psychopharmacol Bull; 1988; 24(2):264-8. PubMed ID: 3212160
    [No Abstract]   [Full Text] [Related]  

  • 24. Visual perception process in amphetamine psychosis and schizophrenia.
    Kojima T; Matsushima E; Iwama H; Ando H; Moriya H; Ando K; Takahashi R; Shimazono Y
    Psychopharmacol Bull; 1986; 22(3):768-73. PubMed ID: 3797583
    [No Abstract]   [Full Text] [Related]  

  • 25. Single-dose effects of amphetamine on smooth pursuit eye movements in man.
    Filip V; David I; Filipová M
    Act Nerv Super (Praha); 1978 Dec; 20(4):293-5. PubMed ID: 367041
    [No Abstract]   [Full Text] [Related]  

  • 26. Oculogyric crises and schizophrenia.
    Rogers DG
    Br J Psychiatry; 1989 Oct; 155():569-70. PubMed ID: 2535646
    [No Abstract]   [Full Text] [Related]  

  • 27. Somatostatin-like immunoreactivity in CSF in schizophrenic patients during haloperidol treatment.
    Jolkkonen J; Pitkänen A; Riekkinen PJ; Korpi ER; Kaufmann CA; Weinberger DR
    Biol Psychiatry; 1992 May; 31(9):962-4. PubMed ID: 1637934
    [No Abstract]   [Full Text] [Related]  

  • 28. Kinetics and dynamics of response to haloperidol in acute schizophrenia--A longitudinal study of the therapeutic process.
    Singh MM; Smith JM
    Compr Psychiatry; 1973; 14(5):393-414. PubMed ID: 4741976
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical experience with methylperidol.
    Vinar O; Taussigová D
    Act Nerv Super (Praha); 1965 Aug; 7(3):250-2. PubMed ID: 5882098
    [No Abstract]   [Full Text] [Related]  

  • 30. Pendulum eye-tracking in remitted psychiatric patients.
    Salzman LF; Klein RH; Strauss JS
    J Psychiatr Res; 1978; 14(1-4):121-6. PubMed ID: 722619
    [No Abstract]   [Full Text] [Related]  

  • 31. The "social chemistry" of pharmacological discovery: the haloperidol story. An interview with Dr. Paul Janssen, January 21, 1986. Interview by Stanley Einstein.
    Janssen P
    Int J Addict; 1992 Mar; 27(3):331-46. PubMed ID: 1563889
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Eye-tracking patterns in schizophrenia.
    Science; 1974 Jun; 184(4142):1201-4. PubMed ID: 4833258
    [No Abstract]   [Full Text] [Related]  

  • 33. Schizophrenic syndrome, thyrotoxicosis, and haloperidol.
    Bianco FJ; Lerro FA
    Psychosomatics; 1972; 13(2):120-1. PubMed ID: 4671983
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluid intake patterns in schizophrenia and normal controls.
    Lawson WB; Roy S; Parent M; Herrera J; Karson C; Bigelow L
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):39-44. PubMed ID: 1557505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The several qualities of attention in schizophrenia.
    Holzman PS; Levy DL; Proctor LR
    J Psychiatr Res; 1978; 14(1-4):99-110. PubMed ID: 722642
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of verapamil to treat negative symptoms in schizophrenia.
    Price WA; Pascarzi GA
    J Clin Psychopharmacol; 1987 Oct; 7(5):357. PubMed ID: 3680609
    [No Abstract]   [Full Text] [Related]  

  • 37. Eye movements in remitting and non-remitting schizophrenia.
    Kojima T; Matsushima E; Moriya H; Ando K; Takahashi R; Shimazono Y; Kharazmi M; Herrera J; Potkin S
    Clin Neuropharmacol; 1986; 9 Suppl 4():277-9. PubMed ID: 3567944
    [No Abstract]   [Full Text] [Related]  

  • 38. Eye-movement consistency and relationship to the process-reactive dimension in schizophrenia.
    Hustmyer FE
    Percept Mot Skills; 1969 Oct; 29(2):448-50. PubMed ID: 5361706
    [No Abstract]   [Full Text] [Related]  

  • 39. Schizophrenia and the scanning cognitive control: a reevaluation.
    McKinnon T; Singer G
    J Abnorm Psychol; 1969 Apr; 74(2):242-8. PubMed ID: 5783241
    [No Abstract]   [Full Text] [Related]  

  • 40. A MODIFICATION OF A PROPOSED MODEL FOR THE EYE TRACKING MOVEMENTS.
    PAVLIDIS T
    IEEE Trans Biomed Eng; 1964; 11():52. PubMed ID: 14185950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.